<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01013636</url>
  </required_header>
  <id_info>
    <org_study_id>3960</org_study_id>
    <nct_id>NCT01013636</nct_id>
  </id_info>
  <brief_title>Human Anaplasmosis in Eastern France</brief_title>
  <official_title>Epidemiology and Clinical Presentation of Human Anaplasmosis in Eastern France</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anaplasmosis is a tick-borne transmitted infection. Its clinical expression include fever,
      cytopenia and hepatitis.This infection was initially described in United States. In Europe,
      its epidemiology is not well known. Some isolated cases have been diagnosed in several
      country, were the tick Ixodes ricinus is known to transmitted another infection :the Lyme
      borreliosis.The purpose of our study is to look systematically for Anaplasmosis, in patient
      living in Eastern France, and presenting with compatible clinical symptoms using a new
      diagnosis tool : PCR in blood samples. So we will have new data about epidemiology in our
      country and the clinical symptoms that are associated with Anaplasmosis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <primary_completion_date type="Anticipated">April 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk factor, clinical and biological markers of infection for patients with Anaplasma antibody seroconversion</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Anaplasmosis</condition>
  <condition>Tick-borne Disease</condition>
  <condition>Ehrlichia</condition>
  <arm_group>
    <arm_group_label>Anaplasma</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>Anaplasma diagnosis test : serology and PCR
If presence of Anaplasma infection, proposition of treatment with doxycylin 200 mg once-a-day during 10 days</description>
    <arm_group_label>Anaplasma</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with Anaplasma phagocytophilia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with at least one of following symptoms : fever or muscular pain or articular
             pain or respiratory signs or neurological signs or meningitis or erythema occurring
             during the three weeks after a tick bite-

          -  Or

          -  patient with fever with at least one of following criteria : thrombocytopenia,
             leucopenia, hepatitis, without any other cause that can explain these abnormalities.

          -  Or

          -  patient with tick-borne encephalitis, or primary stage Lyme borreliosis

        Exclusion Criteria:

          -  children less that 10 years

          -  pregnancy

          -  patients with an other diagnosis that can explain clinical symptoms or biological
             abnormalities

          -  antibiotherapy with cyclins during the days before inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>YVES HANSMANN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service des Maladies Infectieuses et Tropicales Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yves HANSMANN, MD</last_name>
    <phone>33.3.69.55.05.45</phone>
    <email>yves.hansmann@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service des Maladies Infectieuses et Tropicales - CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>BRUNO HOEN, MD</last_name>
      <phone>33.3.81.21.85.33</phone>
      <email>Bruno.hoen@univ-fcomte.fr</email>
    </contact>
    <investigator>
      <last_name>BRUNO HOEN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Colmar</name>
      <address>
        <city>Colmar</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MARTIN MARTINOT, MD</last_name>
      <phone>33.3.89.12.41.23</phone>
      <email>martin.martinot@ch-colmar.rss.fr</email>
    </contact>
    <investigator>
      <last_name>MARTIN MARTINOT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>MAHSA MOHSENI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Département d'Infectiologie CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LIONEL PIROTH, MD</last_name>
      <phone>33.3.80.29.33.05</phone>
      <email>Lionel.piroth@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>LIONEL PIROTH, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Guebwiller</name>
      <address>
        <city>Guebwiller</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GENEVIEVE BOESS, MD</last_name>
      <phone>33.3.89.74.78.00</phone>
      <email>genevieve.boess@ch-guebwiller.fr</email>
    </contact>
    <investigator>
      <last_name>GENEVIEVE BOESS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Haguenau</name>
      <address>
        <city>Haguenau</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BERNARD WILLEMIN, MD</last_name>
      <phone>33.3.88.06.33.33</phone>
      <email>bernard.willemin@ch-haguenau.fr</email>
    </contact>
    <investigator>
      <last_name>BERNARD WILLEMIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>REGIS DUKIC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Mulhouse</name>
      <address>
        <city>Mulhouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JOY MOOTIEN, MD</last_name>
      <phone>33.3.89.64.86.87</phone>
      <email>mootieny@ch-mulhouse.fr</email>
    </contact>
    <investigator>
      <last_name>JOY MOOTIEN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>PIERRE KIEFFER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service des Maladies Infectieuses et Tropicales - CHU de Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CHRISTIAN RABAUD, MD</last_name>
      <phone>33.3.83.15.40.97</phone>
      <email>c.Rabaud@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>CHRISTIAN RABAUD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Médecine Interne et Maladies Infectieuses - CHU de Reims</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CHRISTOPHE STRADY, MD</last_name>
      <phone>33.3.26.78.78.94</phone>
      <email>cstrasdy@chu-reims.fr</email>
    </contact>
    <investigator>
      <last_name>CHRISTOPHE STRADY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Saverne</name>
      <address>
        <city>Saverne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ELISABETH WURTZ, MD</last_name>
      <phone>33.3.88.71.67.67</phone>
      <email>elisabeth.wurtz@ch-saverne.fr</email>
    </contact>
    <investigator>
      <last_name>ELISABETH WURTZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service des Maladies Infectieuses et Tropicales Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YVES HANSMANN, MD</last_name>
      <phone>33.3.69.55.05.45</phone>
      <email>yves.hansmann@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>YVES HANSMANN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>GUILLAUME CAMUSET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>NICOLAS LEFEBVRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>DANIEL CHRISTMANN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benoît JAULHAC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvie DE MARTINO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Sélestat</name>
      <address>
        <city>Sélestat</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FRANCOIS SAGEZ, MD</last_name>
      <phone>33.3.88.57.55.55</phone>
      <email>francois.sagez@ch-selestat.fr</email>
    </contact>
    <investigator>
      <last_name>FRANCOIS SAGEZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Wissembourg</name>
      <address>
        <city>Wissembourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ANDRE MICHEL, MD</last_name>
      <phone>33.3.88.54.11.11</phone>
      <email>amichel@ch-wissembourg.fr</email>
    </contact>
    <investigator>
      <last_name>ANDRE MICHEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2009</study_first_submitted>
  <study_first_submitted_qc>November 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2009</study_first_posted>
  <last_update_submitted>August 29, 2011</last_update_submitted>
  <last_update_submitted_qc>August 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2011</last_update_posted>
  <responsible_party>
    <name_title>Christine GEILLER/ Directeur de la recherche clinique et des innovations</name_title>
    <organization>University Hospital, Strasbourg, France</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tick-Borne Diseases</mesh_term>
    <mesh_term>Anaplasmosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

